BLIS Technologies Limited logo

Patent issue settled and new 5 year agreement with BSP

Legal1 July 2025BLTConsumer Staples

BLIS Technologies Limited: Ground Floor, 399 Moray Place, Dunedin Central 9016, PO Box 2208, Dunedin 9044, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz






2 July 2025


Patent issue settled and new 5 year agreement with BSP

On 14 October 2024, based on the information we had on hand at the time, we advised the market

about a breach of contract by Bluestone Pharma GmbH (BSP) and Lactosan GmbH & Co. KG

(Lactosan).

Since then, BSP and BLIS Technologies Limited (BLIS) have been progressing communications in

relation to the patent applications filed by BSP. BLIS and BSP are pleased to report that these

negotiations have concluded, with BSP and BLIS agreeing that the patent applications will be jointly

owned. This is a positive step forward for both BLIS, BSP and Lactosan, and provides certainty of

access for BLIS and its licensees to this market leading technology developed, and contributed to, by

BLIS, BSP and Lactosan. As part of this arrangement, BLIS, BSP and Lactosan have released each

other of all claims and causes of action arising from the publication of the patent applications.

BLIS would like to thank both BSP and Lactosan for their willingness to engage positively on this

matter and the transparent and ethical manner in which both parties have conducted themselves

during the course of the negotiations.

BLIS and BSP are also pleased to announce they have renegotiated a five year extension to their

existing supply agreement that was scheduled to expire this month.

Ends


For further information, please contact:


Scott Johnson

CEO

+64 21 488 831


About BLIS Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS

®

products are sold throughout New Zealand

and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at

www.blis.co.nz.


Website: www.blis.co.nz

Instagram: @blisprobiotics #blisk12 #blism18 #blisq24

Facebook: @BLISProbiotics

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.